Severe hypoxia drives loss of ST6GAL1-mediated α2,6-sialylation in the epicardial secretome impairing angiogenic activity
Biology Open · 15.04.2026 · 15 (4)
DOI: 10.1242/bio.062479 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biology Open, online erschienen am 29.04.2026. Verfasst von Junqing Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: National Heart and Lung Institute, Imperial College London, London W12 0NN, United Kingdom. Hauptthemen laut MEDLINE: Antigens, CD, beta-D-Galactoside alpha 2-6-Sialyltransferase, Sialyltransferases, Secretome. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: California Institute for Regenerative Medicine, British Heart Foundation, Wellcome Trust.
Abstract (Originalsprache)
The epicardium contributes to cardiac development and regeneration, primarily through paracrine signalling. However, the impact of severe hypoxic stress, such as occurs immediately following myocardial infarction, on the activity of the epicardial secretome remains poorly defined. Here we investigated the angiogenic potential of the epicardial secretome under normoxic and hypoxic conditions. In contrast to expectation, the results demonstrate that the angiogenic effect of epicardial cells on vascular endothelium is hampered under severe hypoxia. Mechanistically, we found that hypoxia-mediated sialylation remodels the epicardial secretome altering its angiogenic potential. Severe hypoxia suppresses St6gal1 gene expression decreasing the level of α2,6-sialylation, as measured by comprehensive lectin profiling and sialyltransferase analysis. Functional studies revealed that both global and α2,6-specific sialylation inhibition markedly compromised the pro-angiogenic capacity of the epicardial secretome, reducing the in vitro tube formation. Our findings indicate that ST6GAL1-dependent α2,6-sialylation is required to activate the pro-angiogenic potential of the epicardial secretome. These data also suggest that glycosylation is a modifiable response to ischemic injury, offering a new therapeutic target for enhancing tissue repair.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Heart and Lung Institute, Imperial College London, London W12 0NN, United Kingdom.
- Section of Bioanalytical Chemistry, Division of Systems Medicine, Faculty of Medicine, Imperial College London, London W12 0NN, United Kingdom.
- National Phenome Centre and Imperial Clinical Phenotyping Centre, Department of Metabolism, Digestion and Reproduction, Imperial College London, London W12 0NN, United Kingdom.
- Regencor, Inc, California 94070, USA.
ORCID-Profile: Junqing Zhang, Harry J Whitwell, Costanza Emanueli, Pilar Ruiz-Lozano
Förderung
- California Institute for Regenerative Medicine
- British Heart Foundation
- Wellcome Trust
- Biotechnology and Biological Sciences Research Council
- Regencor
Zitieren
APA
Zhang, J., Whitwell, H. J., Emanueli, C., & Ruiz-Lozano, P. (2026). Severe hypoxia drives loss of ST6GAL1-mediated α2,6-sialylation in the epicardial secretome impairing angiogenic activity. Biology Open, 15(4). https://doi.org/10.1242/bio.062479
Vancouver
Zhang J, Whitwell HJ, Emanueli C, Ruiz-Lozano P. Severe hypoxia drives loss of ST6GAL1-mediated α2,6-sialylation in the epicardial secretome impairing angiogenic activity. Biology Open. 2026;15(4). doi:10.1242/bio.062479
BibTeX
@article{Zhang2026,
author = {Zhang, Junqing and Whitwell, Harry J and Emanueli, Costanza and Ruiz-Lozano, Pilar},
title = {Severe hypoxia drives loss of ST6GAL1-mediated α2,6-sialylation in the epicardial secretome impairing angiogenic activity},
journal = {Biology Open},
year = {2026},
volume = {15},
number = {4},
doi = {10.1242/bio.062479}
}
EUVIMED